Expression of functional toll like receptor 4 in estrogen receptor/progesterone receptor-negative breast cancer

被引:0
|
作者
Meliha Mehmeti
Roni Allaoui
Caroline Bergenfelz
Lao H. Saal
Stephen P. Ethier
Martin E. Johansson
Karin Jirström
Karin Leandersson
机构
[1] Lund University,Center for Molecular Pathology, Department of Translational Medicine
[2] Lund University,Division of Oncology and Pathology, Department of Clinical Sciences
[3] Medical University of South Carolina,Department of Pathology and Laboratory Medicine, Hollings Cancer Center
来源
Breast Cancer Research | / 17卷
关键词
Breast Cancer; Estrogen Receptor; Breast Cancer Cell; TLR4 Expression; TLR4 Protein Expression;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Expression of functional toll like receptor 4 in estrogen receptor/progesterone receptor-negative breast cancer
    Mehmeti, Meliha
    Allaoui, Roni
    Bergenfelz, Caroline
    Saal, Lao H.
    Ethier, Stephen P.
    Johansson, Martin E.
    Jirstrom, Karin
    Leandersson, Karin
    BREAST CANCER RESEARCH, 2015, 17
  • [2] Increased androgen receptor expression in estrogen receptor-positive/progesterone receptor-negative breast cancer
    Garcia, Ximena
    Elia, Andres
    Galizzi, Lucrecia
    May, Maria
    Spengler, Eunice
    Martinez Vazquez, Paula
    Burruchaga, Javier
    Gass, Hugo
    Lanari, Claudia
    Lamb, Caroline A.
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 180 (01) : 257 - 263
  • [3] Increased androgen receptor expression in estrogen receptor-positive/progesterone receptor-negative breast cancer
    Ximena García
    Andrés Elía
    Lucrecia Galizzi
    María May
    Eunice Spengler
    Paula Martínez Vázquez
    Javier Burruchaga
    Hugo Gass
    Claudia Lanari
    Caroline A. Lamb
    Breast Cancer Research and Treatment, 2020, 180 : 257 - 263
  • [4] Characterization of estrogen receptor-negative/progesterone receptor-positive breast cancer
    Shen, Tiansheng
    Brandwein-Gensler, Margaret
    Hameed, Omar
    Siegal, Gene P.
    Wei, Shi
    HUMAN PATHOLOGY, 2015, 46 (11) : 1776 - 1784
  • [5] Toll-like receptor 4 as a predictor of clinical outcomes of estrogen receptor-negative breast cancer in Saudi women
    Semlali, Abdelhabib
    Jalouli, Maroua
    Parine, Narasimha Reddy
    Al Amri, Abdullah
    Arafah, Maha
    Al Naeem, Abdulrahman
    Ajaj, Sanaa Abdullah
    Rouabhia, Mahmoud
    Alanazi, Mohammad Saud
    ONCOTARGETS AND THERAPY, 2017, 10 : 1207 - 1216
  • [6] Natural history of estrogen receptor-negative, progesterone receptor-positive breast cancer
    Nikoic-Vukosavljevic, D
    Kanjer, K
    Neskovic-Konstantinovic, Z
    Vukotic, D
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2002, 17 (03): : 196 - 200
  • [7] Estrogen Receptor Positive and Progesterone Receptor-negative Breast Cancer: The Role of Hormone Therapy
    Habibi, Mehran
    Canner, Joseph
    Dembinski, Robert
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (SUPPL 2) : S467 - S467
  • [8] Estrogen receptor-positive, progesterone receptor-negative breast cancer: Association with growth factor receptor expression and tamoxifen resistance
    Arpino, G
    Weiss, H
    Lee, AV
    Schiff, R
    De Placido, S
    Osborne, CK
    Elledge, RM
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (17): : 1254 - 1261
  • [9] Targeting Androgen Receptor in Estrogen Receptor-Negative Breast Cancer
    Ni, Min
    Chen, Yiwen
    Lim, Elgene
    Wimberly, Hallie
    Bailey, Shannon T.
    Imai, Yuuki
    Rimm, David L.
    Liu, X. Shirley
    Brown, Myles
    CANCER CELL, 2011, 20 (01) : 119 - 131
  • [10] Targeting androgen receptor in estrogen receptor-negative breast cancer
    Ni, Min
    Chen, Yiwen
    Bailey, Shannon T.
    Imai, Yuuki
    Liu, X. Shirley
    Brown, Myles
    CANCER RESEARCH, 2011, 71